• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human TMEM267 Polyclonal Antibody

The antibody against TMEM267 was raised in rabbit using the Recombinant Human Transmembrane protein 267 protein (1-76AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, IF.

ADC-20380A

The antibody against TMEM267 was raised in rabbit using the Recombinant Human Transmembrane protein 267 protein (1-76AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, IF.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-20380A ClonalityPolyclonal
Host SpeciesRabbitTarget NameTMEM267
Target SynonymsTMEM267; C5orf28; Transmembrane protein 267FormLiquid
Species ReactivityHumanIsotypeIgG
Storage Buffer0.01M PBS, 0.03% Proclin 300; Constituents: 50% Glycerol, PH 7.4Purification Method>95%, Protein G purified
ConjugateNon-conjugatedApplicationELISA, IF
StorageUpon receipt

Immunogen Information


Immunogen DescriptionRecombinant Human Transmembrane protein 267 protein (1-76AA)Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ0VDI3
Background Information
  • Uniprot Id

    Q0VDI3

  • Target Species

    Human

  • Target Name

    TMEM267

  • Target Full Name

    Transmembrane protein 267

  • Target Subcellular Location

    Membrane; Multi-pass membrane protein.

  • Target Synonyms

    TMEM267; C5orf28; Transmembrane protein 267

Inquire Rabbit anti-Human TMEM267 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification